Literature DB >> 20230369

Hot topic: biology in anticancer treatment.

Bruno Vincenzi.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20230369     DOI： 10.2174/156800910790980214

Source DB:  PubMed          Journal:  Curr Cancer Drug Targets        ISSN： 1568-0096            Impact factor:   3.428


× No keyword cloud information.
  3 in total

1.  HER3 Targeting Sensitizes HNSCC to Cetuximab by Reducing HER3 Activity and HER2/HER3 Dimerization: Evidence from Cell Line and Patient-Derived Xenograft Models.

Authors:  Dongsheng Wang; Guoqing Qian; Hongzheng Zhang; Kelly R Magliocca; Sreenivas Nannapaneni; A R M Ruhul Amin; Michael Rossi; Mihir Patel; Mark El-Deiry; J Trad Wadsworth; Zhengjia Chen; Fadlo R Khuri; Dong M Shin; Nabil F Saba; Zhuo G Chen
Journal:  Clin Cancer Res       Date:  2016-06-29       Impact factor: 12.531

2.  Novel, Broad Spectrum Anti-Cancer Agents Containing the Tricyclic 5:7:5-Fused Diimidazodiazepine Ring System.

Authors:  Atul Kondaskar; Shilpi Kondaskar; Raj Kumar; James C Fishbein; Nidal Muvarak; Rena G Lapidus; Mariola Sadowska; Martin J Edelman; Guus M Bol; Farhad Vesuna; Venu Raman; Ramachandra S Hosmane
Journal:  ACS Med Chem Lett       Date:  2010-12-31       Impact factor: 4.345

Review 3.  Emerging role of sphingosine-1-phosphate signaling in head and neck squamous cell carcinoma.

Authors:  Rajeev Nema; Supriya Vishwakarma; Rahul Agarwal; Rajendra Kumar Panday; Ashok Kumar
Journal:  Onco Targets Ther       Date:  2016-05-31       Impact factor: 4.147
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.